.: ORİJİNAL ARAŞTIRMA
Comparison Of Dexmedetomidine and Morphine For Postoperative Pain and Sedation Management in Pediatric Patients Undergoing Congenital Cardiac Surgery: A Retrospective Study
Konjenital Kalp Cerrahisi Geçiren Pediatrik Hastalarda Postoperatif Ağrı ve Sedasyon Yönetimi İçin Deksmedetomidin Ve Morfinin Karşılaştırılması: Retrospektif Çalışma
Turkiye Klinikleri J Anest Reanim. 2020;18(2):35-43
doi: 10.5336/anesthe.2020-75419
Makale Dili: EN
Tam Metin
ABSTRACT
Objective: In this retrospective study, it was aimed to compare the effects of dexmedetomidine and morphine on postoperative pain, sedation, extubation time and hemodynamics in patients who underwent congenital cardiac surgery. Material and Methods: From December 2012 to December 2013, 46 patients between 1 to 5 years of age, who underwent congenital cardiac surgery were included and divided into two groups based on the sedative regimen used in the postoperative period. Twenty-three patients (Group Morp) received morphine at an infusion dose of 0.01 to 0.04 mg/kg/h; 23 patients (Group Dex) received dexmedetomidine at an infusion dose of 0.05 to 0.5 mcg/kg/h. Pain scores were measured using Children's Hospital Eastern Ontario Pain Scale (CHEOPS); sedation scores with the Ramsay Sedation Scale (RSS); and hemodynamic parameters were recorded with these measured values. Sedation debth was monitored by using the Bispectral Index (BIS). In this retrospective study, postoperative pain, sedation and hemodynamic effects of intravenous dexmedetomidine in pediatric patients undergoing congenital cardiac surgery, and the effects of mechanical ventilation duration and length of intensive care unit (ICU) stay were compared with morphine. Results: Mean doses of morphine and dexmedetomidine infused were 7.04±3.94 mg/24 h and 94.33±48.38 mcg/24 h, respectively. BIS values were higher in Group Dex than Group Morp (p<0.01). Mechanical ventilation duration was shorter in Group Dex compared to Group Morp 5.74±1.98 hours vs 7.83±3.08 hours) (p<0.05). The length of ICU stay and other outcome measurements between the two groups were similar. Heart rate was lower in the group Dex only in the first two hours (p<0.01). CHEOPS pain scores were similar in two groups (p> 0.05). RSS scores at 1st, 2nd, 3rd, 4th hours were higher in Group Dex than Group Morp (p <0.01); however, there was no difference between the groups in terms of RSS scores at the 12th, 16th, 20th and 24th hours (p> 0.05). There was no difference between the groups in terms of the frequency of side effects (p> 0.05). Conclusion: With regard to our study findings, dexmedetomidine can provide effective analgesia and sedation with shorter mechanical ventilation duration without adverse reaction compared to morphine in pediatric patients undergoing congenital cardiac surgery.
Keywords: Dexmedetomidine; morphine; postoperative pain; cardiac surgical procedures; pediatrics
Objective: In this retrospective study, it was aimed to compare the effects of dexmedetomidine and morphine on postoperative pain, sedation, extubation time and hemodynamics in patients who underwent congenital cardiac surgery. Material and Methods: From December 2012 to December 2013, 46 patients between 1 to 5 years of age, who underwent congenital cardiac surgery were included and divided into two groups based on the sedative regimen used in the postoperative period. Twenty-three patients (Group Morp) received morphine at an infusion dose of 0.01 to 0.04 mg/kg/h; 23 patients (Group Dex) received dexmedetomidine at an infusion dose of 0.05 to 0.5 mcg/kg/h. Pain scores were measured using Children's Hospital Eastern Ontario Pain Scale (CHEOPS); sedation scores with the Ramsay Sedation Scale (RSS); and hemodynamic parameters were recorded with these measured values. Sedation debth was monitored by using the Bispectral Index (BIS). In this retrospective study, postoperative pain, sedation and hemodynamic effects of intravenous dexmedetomidine in pediatric patients undergoing congenital cardiac surgery, and the effects of mechanical ventilation duration and length of intensive care unit (ICU) stay were compared with morphine. Results: Mean doses of morphine and dexmedetomidine infused were 7.04±3.94 mg/24 h and 94.33±48.38 mcg/24 h, respectively. BIS values were higher in Group Dex than Group Morp (p<0.01). Mechanical ventilation duration was shorter in Group Dex compared to Group Morp 5.74±1.98 hours vs 7.83±3.08 hours) (p<0.05). The length of ICU stay and other outcome measurements between the two groups were similar. Heart rate was lower in the group Dex only in the first two hours (p<0.01). CHEOPS pain scores were similar in two groups (p> 0.05). RSS scores at 1st, 2nd, 3rd, 4th hours were higher in Group Dex than Group Morp (p <0.01); however, there was no difference between the groups in terms of RSS scores at the 12th, 16th, 20th and 24th hours (p> 0.05). There was no difference between the groups in terms of the frequency of side effects (p> 0.05). Conclusion: With regard to our study findings, dexmedetomidine can provide effective analgesia and sedation with shorter mechanical ventilation duration without adverse reaction compared to morphine in pediatric patients undergoing congenital cardiac surgery.
Keywords: Dexmedetomidine; morphine; postoperative pain; cardiac surgical procedures; pediatrics
ÖZET
Amaç: Bu retrospektif çalışmada konjenital kalp cerrahisi uygulanan hastalarda deksmedetomidin ve morfinin postoperatif ağrı, sedasyon, ekstübasyon süresi ve hemodinami üzerine etkilerinin karşılaştırılması hedeflenmiştir. Gereç ve Yöntemler: Aralık 2012 - Aralık 2013 tarihleri arasında konjenital kalp ameliyatı geçirmiş 1-5 yaş arası 46 hasta dahil edildi ve ameliyat sonrası dönemde kullanılan sedasyon rejimine göre iki gruba ayrıldı. Yirmi üç hasta (Morp grubu) 0.01-0.04 mg/kg/saat infüzyon dozunda morfin alırken ; 23 hasta (Dex grubu) 0.05-0.5 mcg/kg/saat intravenöz infüzyon dozunda deksmedetomidin almıştır. Ağrı skorları, Children's Hospital Eastern Ontario Ağrı Ölçeği kullanılarak; sedasyon skorları Ramsay Sedasyon Ölçeği ile ölçülmüştür; ve bu ölçülen değerler ile hemodinamik parametreler kaydedilmiştir. Sedasyon derinliği Bispectral Index kullanılarak izlenmiştir. Bu retrospektif çalışmada konjenital kalp cerrahisi geçiren pediyatrik hastalarda intravenöz deksmedetomidinin postoperatif ağrı, sedasyon ve hemodinamik etkileri ile mekanik ventilasyon süresi ile yoğun bakımda kalış süresine olan etkileri morfin ile karşılaştırılmıştır. Bulgular: İnfüze edilen ortalama morfin ve deksmedetomidin dozları sırasıyla 7.04±3.94 mg/24 saat ve 94.33±48.38 mcgµg/24 saat idi. BIS değerleri Dex grubunda Morp grubundan daha yüksekti (p<0.01). Dex grubunda mekanik ventilasyon süresi Morp grubuna göre daha kısaydı (morfin: 7,83±3,08 saat; deksmedetomidin: 5,74±1,98 saat) (p<0.05). İki grup arasında YBÜ'de kalış süresi ve diğer sonuç ölçümleri benzerdi. Kalp hızı deksmedetomidin grubunda sadece ilk iki saatte düşüktü (p<0.01). CHEOPS ağrı skorları iki grupta benzerdi (p>0.05). RSS skorları 1., 2., 3., 4. saatlerde Dex grubunda Morp grubundan daha yüksekti (p<0.01); bununla birlikte 12., 16., 20. ve 24. saatlerde RSS skorları bakımından gruplar arasında fark yoktu (p>0.05). Yan etki görülme sıklığı bakımından da gruplar arasında fark yoktu (p>0.05). Sonuç: Çalışma bulgularımıza göre, deksmedetomidin, konjenital kalp ameliyatı geçiren pediyatrik hastalarda morfine kıyasla yan etki olmadan daha kısa mekanik ventilasyon süresi ile etkili analjezi ve sedasyon sağlayabilmiştir.
Anahtar Kelimeler: Deksmedetomidin; morfin; postoperatif ağrı; kardiyak cerrahi işlemler; pediatri
Amaç: Bu retrospektif çalışmada konjenital kalp cerrahisi uygulanan hastalarda deksmedetomidin ve morfinin postoperatif ağrı, sedasyon, ekstübasyon süresi ve hemodinami üzerine etkilerinin karşılaştırılması hedeflenmiştir. Gereç ve Yöntemler: Aralık 2012 - Aralık 2013 tarihleri arasında konjenital kalp ameliyatı geçirmiş 1-5 yaş arası 46 hasta dahil edildi ve ameliyat sonrası dönemde kullanılan sedasyon rejimine göre iki gruba ayrıldı. Yirmi üç hasta (Morp grubu) 0.01-0.04 mg/kg/saat infüzyon dozunda morfin alırken ; 23 hasta (Dex grubu) 0.05-0.5 mcg/kg/saat intravenöz infüzyon dozunda deksmedetomidin almıştır. Ağrı skorları, Children's Hospital Eastern Ontario Ağrı Ölçeği kullanılarak; sedasyon skorları Ramsay Sedasyon Ölçeği ile ölçülmüştür; ve bu ölçülen değerler ile hemodinamik parametreler kaydedilmiştir. Sedasyon derinliği Bispectral Index kullanılarak izlenmiştir. Bu retrospektif çalışmada konjenital kalp cerrahisi geçiren pediyatrik hastalarda intravenöz deksmedetomidinin postoperatif ağrı, sedasyon ve hemodinamik etkileri ile mekanik ventilasyon süresi ile yoğun bakımda kalış süresine olan etkileri morfin ile karşılaştırılmıştır. Bulgular: İnfüze edilen ortalama morfin ve deksmedetomidin dozları sırasıyla 7.04±3.94 mg/24 saat ve 94.33±48.38 mcgµg/24 saat idi. BIS değerleri Dex grubunda Morp grubundan daha yüksekti (p<0.01). Dex grubunda mekanik ventilasyon süresi Morp grubuna göre daha kısaydı (morfin: 7,83±3,08 saat; deksmedetomidin: 5,74±1,98 saat) (p<0.05). İki grup arasında YBÜ'de kalış süresi ve diğer sonuç ölçümleri benzerdi. Kalp hızı deksmedetomidin grubunda sadece ilk iki saatte düşüktü (p<0.01). CHEOPS ağrı skorları iki grupta benzerdi (p>0.05). RSS skorları 1., 2., 3., 4. saatlerde Dex grubunda Morp grubundan daha yüksekti (p<0.01); bununla birlikte 12., 16., 20. ve 24. saatlerde RSS skorları bakımından gruplar arasında fark yoktu (p>0.05). Yan etki görülme sıklığı bakımından da gruplar arasında fark yoktu (p>0.05). Sonuç: Çalışma bulgularımıza göre, deksmedetomidin, konjenital kalp ameliyatı geçiren pediyatrik hastalarda morfine kıyasla yan etki olmadan daha kısa mekanik ventilasyon süresi ile etkili analjezi ve sedasyon sağlayabilmiştir.
Anahtar Kelimeler: Deksmedetomidin; morfin; postoperatif ağrı; kardiyak cerrahi işlemler; pediatri
REFERANSLAR:
- Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the intensive care unit: a systematic review. JAMA. 2000;283(11):1451-9. [Crossref] [PubMed]
- Maze M, Scarfini C, Cavaliere F. New agents for sedation in the intensive care unit. Crit Care Clin. 2001;17(4):881-97. [Crossref] [PubMed]
- Chrysostomou C, De Toledo JS, Avolio T, Motoa MV, Berry D, Morell VO, et al. Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery? Pediatr Crit Care Med. 2012;13(3):373. [Crossref] [PubMed]
- Venn RM, Bryant A, Hall GM, Grounds RM. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth. 2001;86(5):650-6. [Crossref] [PubMed]
- Pollak U, Serraf A. Pediatric cardiac surgery and pain management: after 40 years in the desert, have we reached the promised land? World J Pediatr Congenit Heart Surg. 2018;9(3):315-25. [Crossref] [PubMed]
- Zeilmaker-Roest GA, Wildschut ED, van Dijk M, Anderson BJ, Breatnach C, Bogers AJJC, et al; Paediatric Analgesia after Cardiac Surgery consortium. An international survey of management of pain and sedation after paediatric cardiac surgery. BMJ Paediatr Open. 2017;1(1):e000046. [Crossref] [PubMed] [PMC]
- McGrath PJ, Johnson G, Goodman JT, Dunn J, Chapman J. CHEOPS: a behavioral scale for rating postoperative pain in children. In: Fields HL, Dubner R, Cervero F, eds. Advances in Pain Research and Therapy. Vol. 9. New York: Raven Press; 1985. p.395-402.
- Rosen DA, Rosen KR, Steelman RJ. Is the BIS monitor vital in children undergoing cardiothoracic surgery. Anesthesiol. 1999;91:1244.
- Lynn A, Nespeca MK, Bratton SL, Strauss SG, Shen DD. Clearance of morphine in postoperative infants during intravenous infusion: the influence of age and surgery. Anesth Analg. 1998;86(5):958-63. [Crossref] [PubMed]
- Liu RZ, Li BT, Zhao GQ. Efficacy of different analgesic or sedative drug therapies in pediatric patients with congenital heart disease undergoing surgery: a network meta-analysis. World J Pediatr. 2019;15(3):235-45. [Crossref] [PubMed]
- Jacobs JP, Jacobs ML, Maruszewski B, Lacour-Gayet FG, Tchervenkov CI, Tobota Z, et al. Initial application in the EACTS and STS Congenital Heart Surgery Databases of an empirically derived methodology of complexity adjustment to evaluate surgical case mix and results. Eur J Cardiothorac Surg. 2012;42(5):775-9. [Crossref] [PubMed] [PMC]
- Sottas CE, Anderson BJ. Dexmedetomidine: the new all-in-one drug in paediatric anaesthesia? Curr Opin Anesthesiol. 2017;30(4):441-51. [Crossref] [PubMed]
- Tobias JD. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med. 2007;8(2):115-31. [Crossref] [PubMed]
- Liu Y, Bian W, Liu P, Zang X, Gu X, Chen W. Dexmedetomidine improves the outcomes in paediatric cardiac surgery: a meta-analysis of randomized controlled trials. Interact Cardiovasc Thorac Surg. 2018;26(5):852-8. [Crossref] [PubMed]
- Nasr VG, DiNardo JA. Sedation and analgesia in pediatric cardiac critical care. Pediatr Crit Care Med. 2016;17(8 Suppl 1):S225-31. [Crossref] [PubMed]
- Chrysostomou C, De Toledo JS, Avolio T, Motoa MV, Berry D, Morell VO, et al. Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery? Pediatr Crit Care Med. 2009;10(6):654-60. [Crossref] [PubMed]
- Abd Aziz N, Chue MC, Yong CY, Hassan Y, Awaisu A, Hassan J, et al. Efficacy and safety of dexmedetomidine versus morphine in post-operative cardiac surgery patients. Int J Clin Pharm. 2011;33(2):150-4. [Crossref] [PubMed]
- Jiang L, Ding S, Yan H, Li Y, Zhang L, Chen X, et al. A retrospective comparison of dexmedetomidine versus midazolam for pediatric patients with congenital heart disease requiring postoperative sedation. Pediatr Cardiol. 2015;36(5):993-9. [Crossref] [PubMed]
- Prasad SR, Simha PP, Jagadeesh AM. Comparative study between dexmedetomidine and fentanyl for sedation during mechanical ventilation in post-operative paediatric cardiac surgical patients. Indian J Anaesth. 2012;56(6):547-52. [Crossref] [PubMed] [PMC]
- Triltsch AE, Welte M, von Homeyer P, Grosse J, Genähr A, Moshirzadeh M, et al. Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study. Crit Care Med. 2002;30(5):1007-14. [Crossref] [PubMed]
- Chen Z, Shao DH, Hang LH. Effects of dexmedetomidine on performance of bispectral index as an indicator of loss of consciousness during propofol administration. Swiss Med Wkly. 2013;143:w13762. [Crossref] [PubMed]
- Pan W, Wang Y, Lin L, Zhou G, Hua X, Mo L. Outcomes of dexmedetomidine treatment in pediatric patients undergoing congenital heart disease surgery: a meta-analysis. Pediatr Anesth. 2016;26(3):239-48. [Crossref] [PubMed]
- Achuff BJ, Nicolson SC, Elci OU, Zuppa AF. Intraoperative dexmedetomidine reduces postoperative mechanical ventilation in infants after open heart surgery. Pediatr Crit Care Med. 2015;16(5):440-7. [Crossref] [PubMed]
- Tobias JD, Berkenbosch JW. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J. 2004;97(5):451-5. [Crossref] [PubMed]
- Wang G, Niu J, Li Z, Lv H, Cai H. The efficacy and safety of dexmedetomidine in cardiac surgery patients: a systematic review and meta-analysis. PLoS One. 2018;13(9):e0202620. [Crossref] [PubMed] [PMC]
.: İşlem Listesi